DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

The New England Journal of Medicine 

10 Shattuck Street

Boston  Massachusetts  02115-6094  U.S.A.
Phone: 617-734-9800 Fax: 617-739-9864


SEARCH JOBS










 Company News
Stryker Release: Study Published In The New England Journal of Medicine Finds Intra-Arterial Treatment For Clot Removal Is More Effective At Treating Stroke Than Standard Medical Care 12/17/2014 9:25:38 AM
Phase 3 Results Published In The New England Journal of Medicine Show Superiority Of Pfizer (PFE)’s XALKORI® (crizotinib) Compared To Platinum-Based Chemotherapy In Previously Untreated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer 12/4/2014 10:12:52 AM
Isis Pharmaceuticals, Inc. (ISIS) Release: ISIS-APOCIII Rx Phase 2 Study In Patients With Familial Chylomicronemia Published In The New England Journal of Medicine 12/4/2014 7:16:46 AM
ZS Pharma (ZSPH) Announces Publication Of Results From Phase 3 Study Of ZS-9 In Patients With Hyperkalemia In The New England Journal of Medicine 11/21/2014 11:21:28 AM
Relypsa, Inc. (RLYP) Announces Data Published In The New England Journal of Medicine For Pivotal Phase 3 Program Of Patiromer FOS For The Treatment Of Hyperkalemia 11/21/2014 11:20:05 AM
Perosphere Inc.’s Anticoagulant Reversal Agent Clinical Trial Results Published In The New England Journal of Medicine 11/6/2014 10:35:02 AM
Study Ties New Gene Mutation To Major Breast Cancer Risk, The New England Journal of Medicine Reveals 8/7/2014 7:41:19 AM
Study Published In The New England Journal of Medicine Finds Medtronic, Inc. (MDT) Insertable Cardiac Monitors Detect Atrial Fibrillation In Stroke Patients Better Than Standard Care 6/26/2014 8:32:51 AM
AstraZeneca PLC (AZN) Release: Data Published In The New England Journal of Medicine Demonstrate Naloxegol Improved Opioid-Induced Constipation In Chronic Pain Patients 6/19/2014 12:58:41 PM
Two-Year Results From Pfizer Inc. (PFE)’s XELJANZ® (Tofacitinib Citrate) ORAL Start Study Published In The New England Journal of Medicine 6/19/2014 11:20:11 AM
12345678910...